Atlas Trials

Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.

Clinical trial NCT01902680 · COMPLETED

Trial details

NCT number
NCT01902680
Sponsor
Institut Claudius Regaud
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Localized Prostate Cancer
Start date
2013-08-23
Primary completion
2016-07-07
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.